Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02801318
Other study ID # DELI-SLEEP
Secondary ID
Status Not yet recruiting
Phase N/A
First received July 16, 2015
Last updated October 10, 2016

Study information

Verified date October 2016
Source Poitiers University Hospital
Contact Solène QUENTIN-PALOS, PH
Phone 0549443159
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

Acute confusional states known as delirium frequently occur in Intensive Care Units (ICU), mostly after cardiac surgery, leading to serious consequences. Sleep deprivation has been described in ICU patients and is considered as a risk factor for delirium but its role is still unknown. It is therefore essential to identify whether sleep deprivation and more specifically REM sleep alterations could facilitate occurence of delirium in ICU.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date
Est. primary completion date March 2018
Accepts healthy volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients who had a cardiac surgery with extracorporeal circulation.

- Patients who were extubated at Day 0.

- Patients without any operation or anesthetic complication.

- Patients who speak French.

- Patients without TNC at Day 1.

- Patients who had completed the questionnaires before operation.

Exclusion Criteria:

- Age < 18 years old.

- Delirium at Day 1.

- Central nervous system pathology or psychiatric pathology known and treated.

- Concomitant use of neuropsychiatric treatment before surgery that interferes with sleep.

- Clinical condition alteration before polysomnography exam.

- Continue sedation required before Day 3 polysomnography exam.

- Agitation or clinical alteration that did not allow Day 3 polysomnography exam.

Study Design

N/A


Related Conditions & MeSH terms


Intervention

Procedure:
Polysomnography


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Poitiers University Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary significant difference of REM sleep quantity in polysomnography at day 3 Day 3